Effects of dietary nitrate supplementation in team sport athletes: a systematic review and meta-analysis

Authors: Szymocha, Mikolaj; Nowaczyk, Paulina M; Adamczewski, Jakub; Durkalec-Michalski, Krzysztof

Source journal: Journal of the International Society of Sports Nutrition (2026-12-30)

DOI: 10.1080/15502783.2026.2751378

Abstract

BACKGROUND: Dietary nitrate (NO(3) (-)), typically provided as beetroot juice, increases nitric oxide availability and may reduce the oxygen cost of exercise, improve muscle oxygenation, and delay fatigue. Evidence in team sport athletes, however, remains limited and has not been comprehensively synthesized. This systematic review and meta-analysis evaluate the effects of NO(3) (-) supplementation on team sport-specific performance and related physiological and biochemical outcomes. METHODS: This systematic review and meta-analysis followed PRISMA guidelines (PROSPERO CRD42022358739). PubMed, Scopus, and Web of Science were searched through March 2025 for randomized, placebo-controlled trials investigating acute (single dose) or chronic (>/=2 days, with the final dose taken 2-3 h before exercise) NO(3) (-) supplementation in male or female team sport athletes. Effect sizes (Hedges' g) were synthesized using multilevel random-effects models (REML) with cluster-robust standard errors. Risk of bias was assessed using Cochrane RoB 2.0 and certainty of evidence using GRADE. Robustness analyses, including sensitivity to assumed within-person correlations for crossover trials and Monte Carlo simulations to examine the stability of key contrasts under sparse evidence were performed. RESULTS: Twenty-four trials (n = 365 athletes; 277 males, 88 females) met inclusion criteria. Supplementation increased circulating and salivary NO(3) (-)/NO(2) (-), indicating elevated systemic concentrations. The overall pooled ergogenic effect on performance was small but statistically significant (g = 0.075; 95% CI 0.026-0.124; p = 0.005). In team sport-specific tasks, NO(3) (-) supplementation produced a small but consistent improvement with low heterogeneity and moderate certainty of evidence (g = 0.143; 95% CI 0.041-0.245; p = 0.011). A significant benefit was observed with chronic protocols (g = 0.145; 95% CI 0.076-0.214; p < 0.001), whereas acute protocols showed no clear effects. The chronic-acute contrast was statistically significant (g = 0.118; 95% CI 0.029-0.207; p = 0.013) but was not robust to more conservative crossover-correlation assumptions, lowering certainty to very low; because chronic protocols also included a final pre-exercise dose, this contrast should not be interpreted as evidence of long-term adaptation. Improvements were most evident in team sport-specific performance tests (moderate certainty), with additional, less certain signals in repeated high-intensity efforts and fatigue-sensitive neuromuscular outcomes (both very low certainty), while single-sprint outcomes and most metabolic/biochemical markers showed no consistent benefit. Cardiorespiratory responses were largely unchanged. Dose-response meta-regressions did not reveal consistent linear or non-linear trends. CONCLUSIONS: NO(3) (-) supplementation provides small, context-dependent ergogenic benefits in team sport athletes, most consistently for team sport-specific performance (moderate certainty), with preliminary signals for repeated high-intensity efforts and fatigue-sensitive neuromuscular performance (both very low certainty). Evidence for moderation by protocol type, sex, and training status remains suggestive but uncertain and is currently insufficient to support specific dosing recommendations. Well-powered, standardized, sex-stratified trials with harmonized outcome measures are needed to clarify key moderators and strengthen applied guidance.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.